ENTERASENSE LIMITED

EnteraSense Limited is a Galway‑based medical‑device company that has turned cutting‑edge sensor research into a practical solution for one of the most pressing challenges in acute care – Upper Gastrointestinal Bleeding (UGIB). Founded in 2015 by a team of clinicians and engineers from Brigham and Women’s Hospital and Harvard Medical School, the firm holds a licensed technology agreement that underpins its proprietary diagnostic platform.

The core offering is a miniature, ingestible capsule – PillSense – equipped with a highly sensitive sensor capable of detecting the presence of blood in the stomach and providing real‑time monitoring of UGIB. By delivering early, reliable data to clinicians, the technology enables prompt intervention, improving patient outcomes and reducing the substantial morbidity and cost associated with delayed diagnosis. EnteraSense’s portfolio also includes ongoing development of complementary hardware and software tools to support seamless integration into hospital workflows.

With a multidisciplinary team spanning commercial, technical, regulatory and clinical expertise, EnteraSense serves hospitals, gastroenterology units and emergency departments seeking innovative, evidence‑based solutions for rapid UGIB detection and management.